Table 3.

Incidence rates with 95% CI of hospitalized infections overall and by potentially vaccine-preventable organisms of HCT vs comparison groups

HCTNon-HCTDOL
Infection type*Events, nIncidence per 1000 PYs (95% CI)Events, nIncidence per 1000 PYs (95% CI)Events, nIncidence per 1000 PYs (95% CI)
H influenzae 13 1.3 (0.7-2.2) 16 0.5 (0.3-0.8) 0.05 (0.02-0.1) 
Hepatitis A — — 0.01 (0.001-0.06) 
Hepatitis B 11 1.1 (0.6-2.0) 10 0.3 (0.2-0.6) 0.08 (0.04-0.2) 
Influenza A and B 26 2.6 (1.7-3.8) 13 0.4 (0.2-0.7) 0.08 (0.04-0.2) 
N meningitidis 0.2 (0.05-0.8) — — 
S pneumoniae 30 3.0 (2.1-4.2) 22 0.7 (0.5-1.1) 17 0.16 (0.10-0.25) 
V zoster 46 4.5 (3.4-6.1) 75 2.4 (1.9-3.0) 10 0.1 (0.05-0.2) 
Vaccine-preventable infections, all 126 12.4 (10.4-14.8) 133 4.3 (3.6-5.0) 49 0.4 (0.3-0.6) 
Vaccine-preventable infections, limited 69 6.8 (5.4-8.6) 51 1.6 (1.2-2.1) 30 0.3 (0.2-0.4) 
HCTNon-HCTDOL
Infection type*Events, nIncidence per 1000 PYs (95% CI)Events, nIncidence per 1000 PYs (95% CI)Events, nIncidence per 1000 PYs (95% CI)
H influenzae 13 1.3 (0.7-2.2) 16 0.5 (0.3-0.8) 0.05 (0.02-0.1) 
Hepatitis A — — 0.01 (0.001-0.06) 
Hepatitis B 11 1.1 (0.6-2.0) 10 0.3 (0.2-0.6) 0.08 (0.04-0.2) 
Influenza A and B 26 2.6 (1.7-3.8) 13 0.4 (0.2-0.7) 0.08 (0.04-0.2) 
N meningitidis 0.2 (0.05-0.8) — — 
S pneumoniae 30 3.0 (2.1-4.2) 22 0.7 (0.5-1.1) 17 0.16 (0.10-0.25) 
V zoster 46 4.5 (3.4-6.1) 75 2.4 (1.9-3.0) 10 0.1 (0.05-0.2) 
Vaccine-preventable infections, all 126 12.4 (10.4-14.8) 133 4.3 (3.6-5.0) 49 0.4 (0.3-0.6) 
Vaccine-preventable infections, limited 69 6.8 (5.4-8.6) 51 1.6 (1.2-2.1) 30 0.3 (0.2-0.4) 
*

No cases of pertussis, human papillomavirus, measles, mumps, or rubella were observed.

If hepatitis B and V zoster are excluded.

or Create an Account

Close Modal
Close Modal